​

Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

OverviewForecastFinancialsChart

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 209286.20% institutional investors, 31.48% insiders. Hightower advisors is the largest institutional shareholder, holding 503.53% of AKTX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAkari Therapeutics209286.20%31.48%-209217.68%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Hightower advisors79.24K503.53%$80.03K
Cerity partners23.64K150.25%$23.88K
Independent advisor alliance10.89K69.19%$11.00K
Sabby management179.78K32.93%$210.33K
Palo alto investors lp146.02K26.75%$170.83K
Cresset asset management18.41K3.37%$21.54K
Accent capital management10.00K1.83%$11.70K
Cornerstone planning group5.001.53%$1.00
Newedge advisors6.80K1.25%$7.96K
Eversource wealth advisors44.000.28%$44.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sabby management179.78K0.38%$210.33K
Palo alto investors lp146.02K0.04%$170.83K
Accent capital management10.00K0.01%$11.70K
Independent advisor alliance10.89K0.00%$11.00K
Hightower advisors79.24K0.00%$80.03K
Cresset asset management18.41K0.00%$21.54K
Cerity partners23.64K-$23.88K
Omnia family wealth---
Cornerstone planning group5.00-$1.00
Eversource wealth advisors44.00-$44.00

Top Buyers

HolderShares% AssetsChange
Sabby management179.78K0.38%179.78K
Independent advisor alliance10.89K0.00%10.89K
Newedge advisors6.80K-6.80K
Ifp advisors181.00-181.00
Truvestments capital50.00--

Top Sellers

HolderShares% AssetsChange
Omnia family wealth---28.44K
Eversource wealth advisors44.00--4.33K
Cornerstone planning group5.00--2.00
Cerity partners23.64K--
Truvestments capital50.00--

New Positions

HolderShares% AssetsChangeValue
Sabby management179.78K0.38%179.78K$210.33K
Independent advisor alliance10.89K0.00%10.89K$11.00K
Newedge advisors6.80K-6.80K$7.96K
Ifp advisors181.00-181.00$932.00

Sold Out

HolderChange
Omnia family wealth-28.44K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202514-12.50%683,594-41.58%209,2860.00%860.00%2-33.33%
Sep 30, 20251614.29%1,170,067112.45%7,43573.05%620.00%350.00%
Jun 30, 20251550.00%550,74080.99%10032469.88%5-3200.00%
Mar 31, 202510-28.57%304,298-5.73%-30.53%--100.00%1-
Dec 31, 20241440.00%322,78378.02%1244.43%650.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index1.51K0.01%-
RiverNorth Marketplace Lending Corp1.10K0.00%-
RiverNorth Opportunities509.000.00%-
LUX IM Global Medtech HX64.000.00%-10.20K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 16, 2025Neal James R-Buy$960.27
Dec 16, 2025Neal James R-Buy-
Dec 16, 2025Neal James R-Buy$1.20K
Dec 16, 2025Neal James R-Buy-
Dec 16, 2025Prudo-Chlebosz Raymond-Buy-

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q33-
2025 Q24-
2025 Q1--
2024 Q4--

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 209286.20%, followed by 31.48% insiders and -209217.68% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 382.13%, which Akari Therapeutics exceeds.

Who owns the most shares of Akari Therapeutics?

Akari Therapeutics’s largest shareholders are Hightower advisors (79.24K shares, 503.53%), Cerity partners (23.64K shares, 150.25%), and Independent advisor alliance (10.89K shares, 69.19%). Together, they hold 722.97% of Akari Therapeutics’s total shares outstanding.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is Akari Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Akari Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 179.78K Akari Therapeutics shares, valued at 210.33K$.

Who is the top mutual fund holder of Akari Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Akari Therapeutics shares, with 0.01% of its total shares outstanding invested in 1.51K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools